Cleary Gottlieb has advised Alkermes plc. Alkermes plc has secured $1.525 billion in term loan “A” and term loan “B” facilities, with JPMorgan Chase Bank, N.A....
Alkermes Secures $1.525 Billion Term Loan Facilities
Alkermes to Acquire Avadel Pharmaceuticals in $2.1 Billion Deal
McCann FitzGerald LLP has advised Alkermes plc on the deal, Arthur Cox has assisted Avadel Pharmaceuticals plc . Alkermes plc has entered into an agreement to...
Alkermes plc’s Separation of its Oncology Business
Arthur Cox advises Alkermes plc on the deal. Alkermes plc completed the separation of its oncology business into Mural Oncology plc, a new, independent, publicly traded company...
Alkermes’ Successful Proxy Contest Against Sarissa Capital
Sidley represented Alkermes plc in its successful proxy contest. Willkie represented Sarissa Capital. Alkermes plc (Nasdaq: ALKS) announced that, at the company’s 2023 Annual General Meeting...